Novartis
add_icon

Novartis

1,746.70
+107.10
(6.53%)
Market Cap
4,312.74 Cr
PE Ratio
41.41
Volume
35,178.00
Day High - Low
1,750.00 - 1,640.10
52W High-Low
1,780.00 - 950.00
ann
There are 2 new updates from the company22 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
4,312.74 Cr
EPS
37.74
PE Ratio
41.41
PB Ratio
4.95
Book Value
331.23
EBITDA
132.90
Dividend Yield
1.52 %
Industry
Healthcare
Return on Equity
11.39
Debt to Equity
0.01
Forecast For
Actual

Company News

View All News
Caret
positive
Novartis India Ltd has entered an exclusive distribution agreement with Novartis Healthcare Private Limited for its retina portfolio in India, paying an upfront consideration of ₹10 crore.
positive
Novartis India Limited has acquired the 'Minipress' and 'Minipres' trademarks and related IP rights from Pfizer Inc. USA for ₹1,250.001 crore. The deal closes simultaneously with signing.
neutral
Novartis India Limited filed its Business Responsibility and Sustainability Report for FY26. The filing details environmental metrics, employee welfare, and regulatory compliance for the year ended March 31, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,887.40
#1 4,52,850.48
37.62
#1 61,673.90
12.69
#1 11,565
26.53
43.86
9,404.00
2,49,646.65
84.45
11,067.00
13.95
2,568
65.50
69.30
4,905.00
1,86,570.43
86.68
13,886.20
20.34
2,138
3.28
48.63
1,147.10
1,15,425.10
25.09
27,657.90
17.64
5,026
-34.90
53.47
1,387.70
1,12,104.69
33.60
29,044.60
2.24
3,870
-39.18
40.26
1,899.60
1,02,551.16
92.58
6,867.80
22.01
890
#1 123.93
59.31
1,685.70
96,991.45
25.71
34,145.20
5.56
3,503
25.21
55.93
2,105.20
96,256.59
#1 17.34
29,038.90
#1 26.75
5,356
16.00
25.45
1,146.50
95,694.81
30.02
35,058.60
3.90
4,158
-69.10
37.04
2,307.60
95,302.95
46.39
14,636.40
14.85
1,938
29.13
37.67
Growth Rate
Revenue Growth
-1.28 %
Net Income Growth
-7.63 %
Cash Flow Change
-37.33 %
ROE
-11.36 %
ROCE
-3.50 %
EBITDA Margin (Avg.)
0.93 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
981
771
727
736
569
474
414
433
437
397
398
393
408
Expenses
877
656
631
570
478
426
355
373
314
270
265
260
269
EBITDA
104
115
96
166
91
48
60
60
123
127
133
133
139
Operating Profit %
-0 %
5 %
4 %
-1 %
3 %
3 %
7 %
7 %
17 %
19 %
26 %
27 %
27 %
Depreciation
4
4
4
3
3
13
12
10
6
3
2
2
2
Interest
0
0
1
6
2
6
8
5
2
2
1
1
1
Profit Before Tax
93
111
92
158
86
29
40
-4
115
123
130
130
136
Tax
14
39
35
79
34
19
19
-0
12
38
30
37
37
Net Profit
79
73
57
78
52
10
21
-4
103
85
101
93
98
EPS in ₹
24.75
62.04
19.10
28.43
20.97
4.08
8.46
-1.51
41.86
34.50
40.87
37.74
39.60

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
1,246
1,433
1,150
1,111
982
1,078
1,002
958
983
925
948
978
Fixed Assets
9
7
6
5
15
76
64
24
19
7
5
3
Current Assets
1,063
1,264
973
952
807
813
723
709
677
699
746
768
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1,238
1,426
1,144
1,106
968
1,001
938
934
964
918
943
975
Total Equity & Liabilities
1,246
1,433
1,150
1,111
982
1,078
1,002
958
983
925
948
978
Current Liabilities
211
205
183
330
185
233
159
216
160
157
142
145
Non Current Liabilities
33
35
47
47
38
124
132
50
48
23
21
16
Total Equity
1,002
1,194
920
734
759
721
711
692
776
745
785
818
Reserve & Surplus
986
1,178
906
721
747
708
699
679
763
733
773
806
Share Capital
16
16
14
12
12
12
12
12
12
12
12
12

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
622
-613
51
-38
50
-9
-11
90
-139
26
7
0
Investing Activities
719
-631
424
69
274
56
95
87
-153
33
-3
18
Operating Activities
-60
57
-41
161
-194
-23
-69
39
45
113
75
47
Financing Activities
-38
-39
-332
-268
-30
-41
-37
-36
-31
-121
-64
-64

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Jul 2026
Promoter
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.32 %
0.19 %
0.19 %
0.19 %
0.19 %
0.19 %
0.19 %
0.19 %
0.19 %
0.19 %
0.17 %
0.16 %
0.15 %
DIIs
0.79 %
0.84 %
0.78 %
0.78 %
0.78 %
0.78 %
0.79 %
0.79 %
0.78 %
0.76 %
0.53 %
0.53 %
0.53 %
0.53 %
0.53 %
0.53 %
0.53 %
0.53 %
0.53 %
0.64 %
0.53 %
1.36 %
1.39 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.34 %
23.03 %
23.09 %
22.98 %
22.88 %
22.94 %
23.02 %
23.01 %
23.03 %
23.08 %
23.29 %
23.21 %
22.95 %
23.04 %
23.05 %
23.01 %
23.11 %
22.95 %
22.92 %
22.67 %
23.25 %
22.50 %
22.43 %
Others
5.20 %
5.46 %
5.45 %
5.56 %
5.66 %
5.60 %
5.52 %
5.52 %
5.51 %
5.48 %
5.18 %
5.39 %
5.65 %
5.57 %
5.55 %
5.59 %
5.49 %
5.66 %
5.68 %
5.83 %
5.36 %
5.31 %
5.35 %
No of Share Holders
41,572
43,784
45,141
44,640
44,370
43,996
43,275
42,622
41,947
43,343
43,992
43,128
41,239
39,265
39,596
38,926
39,133
39,040
39,353
39,468
38,116
36,502
36,706

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 10 10 10 10 10 10 47.5 25 25 25
Dividend Yield (%) 1.63 1.46 1.99 1.81 1.7 1.77 7.07 3.18 2.58 1.52

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2026 1,601.50 1,639.90
20 Aug 2021 DIVIDEND Dividend
10.00 /share
17 Aug 2021 906.60 805.65
22 Jul 2022 DIVIDEND Dividend
10.00 /share
20 Jul 2022 610.40 653.30
21 Jul 2023 DIVIDEND Dividend
37.50 /share
20 Jul 2023 624.80 828.65
21 Jul 2023 DIVIDEND Dividend
10.00 /share
20 Jul 2023 624.80 828.65
24 Jul 2024 DIVIDEND Dividend
25.00 /share
23 Jul 2024 1,053.80 1,116.90
31 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2024 1,053.80 1,176.65
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Oct 2024 1,164.25 1,057.05
28 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2025 942.05 903.55
09 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 May 2025 830.10 797.40
23 Jul 2025 DIVIDEND Dividend
25.00 /share
23 Jul 2025 797.40 1,061.45
29 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jul 2025 1,002.90 993.65
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 797.40 995.75
28 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2025 892.00 858.35
28 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2026 775.70 800.75
12 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2026 970.80 1,182.50
23 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jul 2026 1,457.40 1,699.80

Announcements

Intimation Under Reg 30 Of SEBI LODR Regarding Entering Into Exclusive Promotion And Distribution Agreement With Novartis Healthcare Private Limited23 mins ago
Intimation Regarding The Acquisition Of Trademarks "Minipress" And "Minipres" From Pfizer Inc. USA And Pfizer Products Inc. USA The Same Is Approved By The Board Of Directors Of The Company At Their Board Meeting Held Today I.E. September 07 202622 hrs ago
Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Reg. 34 (1) Annual Report.5 days ago
Notice Of The 78Th Annual General Meeting Of Novartis India Limited To Be Held On Thursday September 24 2026 Through Video Conferencing (VC) / Other Audio Visual Means (OAVM)5 days ago
Business Responsibility and Sustainability Reporting (BRSR)5 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On August 17 2026Aug 17, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 07 2026Aug 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 29, 2026
Outcome Of The 247Th Meeting Of The Board Of Directors Held Today I.E Wednesday July 29 2026.Jul 29, 2026
Outcome Of The 246Th Meeting Of The Board Of Directors Held On Today I.E Wednesday July 29 2026.Jul 29, 2026
Announcement under Regulation 30 (LODR)-Resignation of ChairmanJul 29, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 29, 2026
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jul 29, 2026
Change In Control Of The Novartis India Limited ("The Company").Jul 29, 2026
Announcement under Regulation 30 (LODR)-CessationJul 29, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 29, 2026
Disclosure In Terms Of Regulation 29(2) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) ("SAST") 2015.Jul 29, 2026
Disclosure In Terms Of Regulation 7(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015.Jul 29, 2026
Intimation Under Regulation 31A (10) And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations").Jul 29, 2026
Board Meeting Outcome for Outcome Of The 245Th Meeting Of The Board Of Directors Of Novartis India Limited ("The Company") Held Today Wednesday July 29 2026.Jul 29, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2026
Financial Results Of Novartis India Limited For The Quarter Ended June 30 2026.Jul 23, 2026
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited Held On Thursday July 23 2026.Jul 23, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Post-Offer advertisementJul 10, 2026
Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Novartis India Limited ("The Company").Jul 07, 2026
Closure of Trading WindowJun 30, 2026
Updates on Open OfferJun 25, 2026
Updates on Open OfferJun 23, 2026
Updates on Open OfferJun 23, 2026
Updates on Open OfferJun 19, 2026
Updates on Open OfferJun 19, 2026
Updates on Open OfferJun 17, 2026
Updates on Open OfferJun 16, 2026
Updates on Open offerJun 15, 2026
Updates on Open OfferJun 12, 2026
Updates on Open OfferJun 11, 2026
Pre-Offer Advertisement & Corrigendum to Detailed Public StatementJun 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 06, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJun 04, 2026
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJun 04, 2026
Letter of OfferJun 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 19, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMay 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
0.00%
-31934
-1.54%
-0.44%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-21
-0.01%
-0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-0.07%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
-0.12%
HDFC MNC Fund Direct-Growth
0.00%
0
0.00%
-0.53%
HDFC Pharma And Healthcare Fund Direct-Growth
0.00%
0
0.00%
-0.51%

Technical Indicators

RSI(14)
Neutral
60.82
ATR(14)
Volatile
67.70
STOCH(9,6)
Overbought
84.55
STOCH RSI(14)
Overbought
98.65
MACD(12,26)
Bullish
14.66
ADX(14)
Weak Trend
22.33
UO(9)
Bearish
54.33
ROC(12)
Uptrend And Accelerating
10.62
WillR(14)
Neutral
-20.00